Startup Triton Algae Innovations is betting on a whole-cell protein positioning for an algae species that has been researched for years for its nutraceutical and pharmaceutical ingredient production potential.
Australian biotechnology firm Marinova has achieved novel foods status in the EU for its Maritech® fucoidan extracts, and the firm is now targeting growth in the region's functional beverage and supplement sectors.
Dr Dan Fabricant, PhD, executive director of the Natural Products Association, has continued his forceful advocacy of existing compliant paths to market for CBDs in an appearance on The Doctors TV show.
The good news in the botanicals sector is that increasing numbers of systematic reviews and meta-analyses show that there is strong support for the health benefits of these ingredients, said Mark Blumenthal, founder of the American Botanical Council.
Experts expect the existing standoff on synthetic botanicals as voiced by FDA in the most recent draft NDI guidance will continue, despite the consensus from industry being the agency’s position is not rooted in science.
A federal district court judge in Atlanta has ruled in favor of FDA in its case against Hi-Tech Pharmaceuticals over its use of DMAA. But the ruling potentially weakens agency’s stance on the question of synthetic versions of constituents of botanicals.
A call from the U.S. Commerce Department for suggestions on streamlining manufacturing regulations has generated responses from industry trade organizations, with the different tacks the suggestions take reflecting those organizations’ membership.
The updated New Dietary Ingredients draft guidance is an attempt to over regulate and weaken the dietary supplement industry with no increase in public safety, according to comments filed recently by finished goods manufacturer Jarrow Formulas.